CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 56 enrolled
Drug / intervention
Pseudoephedrine +5 moredrug
Likely dose
Pseudoephedrine 120 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01028014
NCT01028014N/ACompleted

Medication Effects on Periurethral Sensation, Urethral Sphincter Activity and Pressure Flow Parameters

University of Alabama at Birmingham·interventional·Posted Dec 9, 2009·Updated Jun 8, 2012

In Brief

A clinical study evaluating Pseudoephedrine, Tamsulosin, and 4 other interventions for Urethral Sphincter Activity. Completed, enrolled 56 participants across 1 site.

Detailed Summary

Lower urinary tract symptoms such as urinary leakage and overactive bladder affect millions of American women. Women may develop these problems because the innervation of the muscles of the bladder and urethra are injured. Most research on treating these problems has focused on the abnormalities of the bladder muscle, but newer studies have shown abnormalities in the innervation and muscle function of the urethra. Women with these symptoms may benefit from treatment with medications to improve their urethral function. However, to truly understand what types of medications will help women with these symptoms, the investigators wish to study how these medications affect innervation and muscle function in healthy women who do not have lower urinary tract symptoms.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsAstellas Pharma Inc

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedDec 9, 2009
Enrollment StartApr 1, 2010
Primary CompletionApr 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 16.6 years ago

Interventions

Pseudoephedrinedrug

Pseudoephedrine ER 120 mg by mouth once daily for 2 weeks

Tamsulosindrug

Tamsulosin 0.4mg by mouth daily for 2 weeks

Imipraminedrug

Imipramine 25mg daily by mouth for 2 weeks

Cyclobenzaprinedrug

Cyclobenzaprine 10mg daily by mouth for 2 weeks

Lactose capsuledrug

Lactose capsule 1 by mouth daily for 2 weeks

Solifenacindrug

Solifenacin 5mg by mouth daily for 2 weeks